Media coverage
3
Media coverage
Title Axsome's Auvelity Becomes First FDA-Approved Oral NMDA For Major Depressive Disorder Media name/outlet BioSpace Country/Territory United States Date 19/08/22 URL https://www.biospace.com/article/fda-approves-first-oral-nmda-for-major-depressive-disorder/ Persons Dan Vlad Iosifescu Title Axsome's Auvelity Becomes First FDA-Approved Oral NMDA For Major Depressive D... Media name/outlet BioSpace Country/Territory United States Date 19/08/22 URL https://www.biospace.com/article/fda-approves-first-oral-nmda-for-major-depressive-disorder/?s=71 Persons Dan Vlad Iosifescu Title Axsome’s Auvelity becomes first FDA-approved oral NMDA for major depressive disorder Media name/outlet Pharma Live Country/Territory United States Date 19/08/22 URL https://www.pharmalive.com/axsomes-auvelity-becomes-first-fda-approved-oral-nmda-for-major-depressive-disorder/ Persons Dan Vlad Iosifescu